Patents by Inventor Michael Amdahl

Michael Amdahl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Shortening of hospital stay and improving survival in patients with chronic kidney disease
    Publication number: 20060154902
    Abstract: Formulations containing a Vitamin D compound or analog, such as paricalcitol (Zemplar™) are useful for shortening hospital stays in chronic kidney disease patients with or without hyperparathyroidism. Also disclosed are methods of shortening hospital stays for chronic kidney disease patients with or without hyperparathyroidism, and methods for determining reduction length of hospital stay in chronic kidney disease patients with or without hyperparathyroidism. Titration to serum calcium or serum PTH is avoided by use of the invention.
    Type: Application
    Filed: August 15, 2003
    Publication date: July 13, 2006
    Inventors: Joel Melnick, Laura Williams, Michael Amdahl, Steven Marx, Mark O'Brien, Angelo Mathes
  • Methods of using vitamin D compounds in the treatment of patients undergoing hemodialysis
    Publication number: 20050192256
    Abstract: The subject invention relates to methods of using Vitamin D compounds such as, for example, paricalcitol and calcitriol, in the treatment of patients undergoing hemodialysis. More specifically, administration of Vitamin D compounds appears to reduce the incidence of hospitalization, length of days spent in the hospital and morbidity in treated patients.
    Type: Application
    Filed: December 2, 2004
    Publication date: September 1, 2005
    Inventors: Joel Melnick, Laura Williams, Michael Amdahl, Jin Tian, Steven Marx, Coleen Hall, Dheerendra Kommala